Correlation Between CanSino Biologics and Merck

Can any of the company-specific risk be diversified away by investing in both CanSino Biologics and Merck at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CanSino Biologics and Merck into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CanSino Biologics and Merck Company, you can compare the effects of market volatilities on CanSino Biologics and Merck and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CanSino Biologics with a short position of Merck. Check out your portfolio center. Please also check ongoing floating volatility patterns of CanSino Biologics and Merck.

Diversification Opportunities for CanSino Biologics and Merck

-0.72

Correlation Coefficient

CanSino Biologics  Merck

Pay attention - limited upside

The 3 months correlation between CanSino and Merck is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding CanSino Biologics and Merck Company in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merck Company and CanSino Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CanSino Biologics are associated (or correlated) with Merck. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merck Company has no effect on the direction of CanSino Biologics i.e., CanSino Biologics and Merck go up and down completely randomly.

Pair Corralation between CanSino Biologics and Merck

Assuming the 90 days horizon CanSino Biologics is expected to under-perform the Merck. In addition to that, CanSino Biologics is 2.61 times more volatile than Merck Company. It trades about -0.02 of its total potential returns per unit of risk. Merck Company is currently generating about -0.02 per unit of volatility. If you would invest  17,364  in Merck Company on September 12, 2024 and sell it today you would lose (3,319) from holding Merck Company or give up 19.11% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

CanSino Biologics  vs.  Merck Company

CanSino Biologics

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in CanSino Biologics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, CanSino Biologics reported solid returns over the last few months and may actually be approaching a breakup point.

Merck Company

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with CanSino Biologics and Merck

The main advantage of trading using opposite CanSino Biologics and Merck positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CanSino Biologics position performs unexpectedly, Merck can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merck will offset losses from the drop in Merck's long position.

The idea behind CanSino Biologics and Merck Company pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.